Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Pagliari MT, Rosendaal FR, Ahmadinejad M, Badiee Z, Baghaipour MR, Baronciani L, Benítez Hidalgo O, Bodó I, Budde U, Castaman G, Eshghi P, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Mannucci PM, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Peyvandi F, Federici AB, Eikenboom J. Pagliari MT, et al. Among authors: ahmadinejad m. J Thromb Haemost. 2022 May;20(5):1106-1114. doi: 10.1111/jth.15658. Epub 2022 Feb 22. J Thromb Haemost. 2022. PMID: 35092343 Free PMC article.
A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
Faranoush M, Abolghasemi H, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M. Faranoush M, et al. Among authors: ahmadinejad m. Clin Appl Thromb Hemost. 2015 Nov;21(8):724-8. doi: 10.1177/1076029614522545. Epub 2014 Mar 19. Clin Appl Thromb Hemost. 2015. PMID: 24651301 Free article. Clinical Trial.
A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor.
Faranoush M, Abolghasemi H, Mahboudi F, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Vaziri B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M. Faranoush M, et al. Among authors: ahmadinejad m. Clin Appl Thromb Hemost. 2016 Mar;22(2):184-90. doi: 10.1177/1076029614555902. Epub 2014 Oct 24. Clin Appl Thromb Hemost. 2016. PMID: 25343955 Free article. Clinical Trial.
Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients.
Abolghasemi H, Panahi Y, Ahmadinejad M, Toogeh G, Karimi M, Eghbali A, Mirbehbahani NB, Dehdezi BK, Badiee Z, Hoorfar H, Eshghi P, Maghsoudi N, Sahebkar A, Gholami-Fesharaki M. Abolghasemi H, et al. Among authors: ahmadinejad m. J Pharmacopuncture. 2018 Jun;21(2):76-81. doi: 10.3831/KPI.2018.21.009. Epub 2018 Jun 30. J Pharmacopuncture. 2018. PMID: 30151307 Free PMC article.
Correlation of bleeding score with frequency and severity of bleeding symptoms in FXIII deficiency assessing by the ISTH Bleeding Assessment Tool.
Naderi M, Cohan N, Haghpanah S, Miri-Aliabad G, Shahramian I, Ahmadinejad M, Sadeghi S, Dorgalaleh A, Khazaei HA, Karimi M. Naderi M, et al. Among authors: ahmadinejad m. Transfus Apher Sci. 2019 Aug;58(4):495-497. doi: 10.1016/j.transci.2019.05.012. Epub 2019 Jul 9. Transfus Apher Sci. 2019. PMID: 31303509 Clinical Trial.
Von Willebrand disease combined with coagulation defects in Iran.
Seidizadeh O, Ahmadinejad M, Homayoun S, Mannucci PM, Peyvandi F. Seidizadeh O, et al. Among authors: ahmadinejad m. Blood Transfus. 2021 Sep;19(5):428-434. doi: 10.2450/2021.0078-21. Epub 2021 May 28. Blood Transfus. 2021. PMID: 34059196 Free PMC article.
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Baronciani L, Peake I, Schneppenheim R, Goodeve A, Ahmadinejad M, Badiee Z, Baghaipour MR, Benitez O, Bodó I, Budde U, Cairo A, Castaman G, Eshghi P, Goudemand J, Hassenpflug W, Hoorfar H, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Mannucci PM, Marino R, Nikšić N, Oyen F, Santoro C, Tiede A, Toogeh G, Tosetto A, Trossaert M, Zetterberg EMK, Eikenboom J, Federici AB, Peyvandi F. Baronciani L, et al. Among authors: ahmadinejad m. Blood Adv. 2021 Aug 10;5(15):2987-3001. doi: 10.1182/bloodadvances.2020003397. Blood Adv. 2021. PMID: 34351388 Free PMC article.
115 results